She had a prior coronary artery bypass grafting and aortic valve replacement in [**2110**].
TE on [**2117-9-21**] showed LVH with EF of 50-55 percent AS, mitral annular calcification with mitral valve thickening, and moderate MR.  Cardiac catheterization performed prior to this admission on [**2117-9-29**] showed severe native three vessel disease with a patent LIMA to the LAD, circumflex 90 percent with a PTI stent, saphenous vein graft to the OM had an 80 percent lesion, RCA 70 percent lesion with significant damping, mild aortic insufficiency, mild aortic arch dilatation.
Spinal meningitis four to seven years ago.
Hematology workup was in progress when the patient was discharged with plans to follow-up with Hematology, Dr. [**Last Name (STitle) **], as an outpatient and return for CABG AVR when hematology issues and platelet issues were controlled.
The platelets at the outside hospital were 110 and transferred in for treatment and consideration for CABG AVR again on [**2117-10-7**].
Lopressor 50 mg p.o.
Norvasc 7.5 mg p.o.
Glyburide 5 mg p.o.
Metformin 1,000 mg p.o.
Lisinopril 20 mg p.o.
Lasix 20 mg daily.
Aspirin 81 mg daily.
Paxil 5 mg daily.
On [**2117-10-11**], the patient underwent redo CABG with a vein graft to the RCA and aortic valve replacement with a 19 mm mosaic porcine tissue valve.
The patient was transferred to the Cardiothoracic Intensive Care Unit in stable condition on a milrinone drip at 0.3 micrograms per kilogram per minute, Amiodarone drip at 2.4 mg per minute, epinephrine 0.04 micrograms per kilogram per minute, Levophed drip at 0.06 micrograms per kilogram per minute, Neo- Synephrine drip at 0.3 micrograms per kilogram per minute, and a titrated propofol drip.
Of note, the patient did have an asystolic cardiac rest at 12:15 a.m. on the morning prior to surgery.
Lasix was held.
The patient received intravenous fluids and 20 of Lasix and remained on Amiodarone, epinephrine, insulin, Levophed, milrinone and propofol drips.
The patient began Plavix, continued Lasix diuresis with the plan to wean epinephrine and keep the patient intubated.
On postoperative day number two, the patient received 1 unit of packed red blood cells for a hematocrit of 26, platelet counts dropped again to 79,000.
The chest tubes were discontinued.
Lasix was increased to 80 twice daily.
Milrinone was decreased down to 0.2.
Amiodarone was switched over from intravenous to oral.
The patient remained in the Intensive Care Unit on face mask after being extubated, saturating 100 percent on 4 liters nasal cannula.
On postoperative day number three, aspirin was decreased to 81, Zantac was changed to Protonix, Amiodarone had been switched to oral, milrinone continued to be decreased, Captopril was added in for blood pressure control.
The patient did not appear to be bleeding, was started on Lopressor beta blockade.
The platelets were transfused so that the pacing wires could be pulled.
The Foley was discontinued and aggressive diuresis was continued.
The patient was screened for rehabilitation, was restarted on oral diabetes medicines as well as restarting the Plavix.
The pacing wires were discontinued.
The patient continued to ambulate as the screening for rehabilitation continued.
The patient continued on beta blockade with a heart rate of 80, in sinus rhythm with a blood pressure of 106/46 as well as intravenous Lasix.
Metformin was added back in.
Lasix was switched over from intravenous to twice daily.
Lasix was increased.
The patient was saturating 96 percent on room air, continued with metformin and Glyburide.
Status post redo coronary artery bypass graft times one    and aortic valve replacement.
Status post aortic valve replacement and coronary artery    bypass graft in [**2110**].
Potassium chloride 20 mEq p.o.
Colace 100 mg p.o.
Enteric coated aspirin 81 mg p.o.
Percocet 5/325 one to two tablets p.o.
Plavix 75 mg p.o.
Metformin 1,000 mg p.o.
Paroxetine hydrochloride 5 mg p.o.
Lasix 40 mg p.o.
three times daily times ten days and then    decrease the dose to Lasix 20 mg p.o.
Metoprolol tartrate 25 mg p.o.
Glyburide 10 mg p.o.
